English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Encoding and display technologies for combinatorial libraries in drug discovery: The coming of age from biology to therapy Review article
2024
Authors:  Fan, Yu;  Feng, Ruibing;  Zhang, Xinya;  Wang, Zhen Liang;  Xiong, Feng; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:14.7/14.1 | Submit date：2024/05/16
Drug Screening  Dna-encoded Chemical Libraries  Phage Display  Peptide-encoded Chemical Libraries  Clinical Drugs  
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Pharmacological therapies and drug development targeting SARS-CoV-2 infection Review article
2022
Authors:  Yizhou Jiang;  Limor Rubin;  Zhiwei Zhou;  Haibo Zhang;  Qiaozhu Su; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.3/10.2 | Submit date：2023/01/30
Clinical Trials  Covid-19  Cytokine Storm  Drugs In clInic  Drugs In Development  Sars-cov-2  
A Therapeutic Journey of Potential Drugs Against COVID-19 Journal article
Ali, Fayaz, Hussain, Shahid, Zhu, Yi Z.. A Therapeutic Journey of Potential Drugs Against COVID-19[J]. Mini-Reviews in Medicinal Chemistry, 2022, 22(14), 1876-1894.
Authors:  Ali, Fayaz;  Hussain, Shahid;  Zhu, Yi Z.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:3.3/3.7 | Submit date：2023/01/30
Approved Drugs  Clinical Trials  Covid-19 Outbreak  Mers-cov  Pandemic  Therapeutic Agents  
Research and development of mAb drugs in China: a look from policy perspectives Journal article
Rong Jiang, Yuanyuan Sun, Carolina Ung, Xinyue Dong, Xiangjun Kong, Yuanjia Hu, Rong Shao. Research and development of mAb drugs in China: a look from policy perspectives[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15(11), 2695-2705.
Authors:  Rong Jiang;  Yuanyuan Sun;  Carolina Ung;  Xinyue Dong;  Xiangjun Kong; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.1/4.2 | Submit date：2020/03/12
r&d Support And Guidance Policy  Clinical Trial Policy  Drug Lag  Innovation Support System  Mab Drugs  Marketing Approval Policy  
Analysis of the Current Situation of Antitumor Drug Use in China: A Hospital-Based Perspective Journal article
Yun-Feng Lai, Jin-Jian Lu, Hao Hu, Yi-Tao Wang. Analysis of the Current Situation of Antitumor Drug Use in China: A Hospital-Based Perspective[J]. Therapeutic Innovation and Regulatory Science, 2015, 49(1), 181.
Authors:  Yun-Feng Lai;  Jin-Jian Lu;  Hao Hu;  Yi-Tao Wang
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date：2018/10/31
Antitumor Drugs  China  Clinical Treatment  Drug Usage  Plant Alkaloids